Details
Category: Volume 07 Issue 11 November 2019
Hits: 1471

Title: Diagnostic Yield of Cartridge Based Nucleic Acid Amplification Test (CBNAAT) in Pulmonary Tuberculosis with   People Living with HIV (PLHIV) Compared to Sputum Microscopy

Authors: Dr Srujana Akella, Dr V.N. Raju, M.D, Dr Gayatri M.D, Dr V. Prathyush M.D, Dr Preethi, M.D

 DOI: https://dx.doi.org/10.18535/jmscr/v7i11.82

Abstract

Introduction: Tuberculosis is a highly infectious disease which is caused by Mycobacterium tuberculosis. Tuberculosis is the most common opportunistic infection in PLHIV, and the risk of death in HIV-TB co-infected individuals are high .In 2017, among HIV-negative people, estimated deaths caused by TB were 1.3 million (range, 1.2–1.4 million) and there were an additional 3,00,000 deaths from TB (range, 2,66,000–3,35,000) among HIV-positive people. we have taken up the study of comparing detection of mycobacterial tuberculosis bacilli in sputum by Xpert/RIF and method in fluroscent smear pulmonary tuberculosis and rifampicin resistance with a special focus on PLHIV

Aims and Objectives

  • To compare the sputum microscopy and cartridge based nucleic acid amplification test (CBNAAT) in diagnosing

pulmonary tuberculosis with people living with HIV (PLHIV).

  • To determine whether there is any correlation between CD4 counts in terms of detection with these two techniques among plhiv patients.

Materials and Methods: One hundred PLHIV patients with age >18 years with symptoms suggestive of tuberculosis who met the criteria were selected. All patients included in the study underwent a detailed history and clinical examination. CD4 lymphocyte counts of all the patients were determined by flow cytometry. Two Sputum samples were collected at least 1ml for each patient, in 2 sterile containers. One was sent for AFB smear examination under fluorescent microscopy.  One sputum sample of 1 ml was collected in a sterile falcon container and was analyzed by CBNAAT on Xpert® MTB/RIF

manufactured by Cepheid, endorsed by WHO (2010).Data analysis was done using Microsoft Excel software. Diagnostic yield of sputum microscopy and CBNAAT were compared with McNemar test.

Observations and Results

  • Total 100 PLHIV patients with presumptive PTB were included in the

Sputum microscopy detected 21 cases and sputum for CBNAAT detected 52 cases. Smear-positive CBNAAT negative cases were 4. A total number of PLHIV patients with pulmonary tuberculosis were 56.

  • CD4 cell count upto 100 cells/ml was seen in 16 patients and PTB was detected in 11(68%) cases by CBNAAT. In 19 patients with CD4 COUNT 101- 200 cells/ml, PTB was detected in 14(73.68%) cases by CBNAAT COUNT >500 cells/ml, PTB was detected in 7(26.92%) cases by CBNAAT. Mean CD4 count was 355.84±281.25 cells/ml. CBNAAT positive and sputum microscopy positive cases were CBNAAT negative and sputum microscopy positive cases were 4.CBNAAT positive and sputum microscopy negative were 35.P-value was 0.0031 (<0.05) which was significant. Out of 52 CBNAAT detected cases, 48 were rifampicin sensitive and 4 were rifampicin resistant.

Conclusion: CBNAAT is to be indicated as a primary diagnostic test in PLHIV with presumptive TB.CBNAAT detects pulmonary TB in PLHIV with greater efficacy than sputum microscopy, also helping in early diagnosis in less than 2 hours. It also detects rifampicin resistance with high specificity and can be used for screening for MDR-TB so that early therapy can be started, thus decreasing the incidence of MDR-TB.

Keywords: PLHIV, sputum microscopy, CBNAAT, Pulmonary tuberculosis, CD4 count.

References

  1. Technical and Operational Guidelines for Tuberculosis Control in India RNTCP 2016.
  2. WHO Tuberculosis, Global Tuberculosis Report pg27
  3. https://www.tborg/tb-india
  4. Corbett EL, Watt CJ, Walker N et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163 (9): 1009- 21.
  5. Dewan R, Anuradha S, Khanna A, Garg S, Singla S, Ish P, et al. Role of cartridge-based nucleic acid amplification test (CBNAAT) for early diagnosis of pulmonary tuberculosis in HIV. Journal, Indian Academy of Clinical Medicine Vol. 16, No. 2 April-June, 2015.
  6. Swaminathan S, Ramachandran R, Baskaran G et al. Risk of development of tuberculosis in HIV-infected patients. Int J Tuberc Lung Dis 2000; 4 (9): 839-44
  7. TB/HIV A clinical manual; 2nd edition, WHO
  8. Mathur M, Badhan RK, Kumari S, Kaur N, Gupta S. Radiological Manifestations of Pulmonary Tuberculosis-A Comparative Study between Immunocompromised and Immunocompetent Patients. Journal of clinical and diagnostic research: JCDR. 2017 Sep;11(9):TC06.
  9. Marais BJ, Brittle W, Painczyk K, Hesseling AC, Beyers N, Wasserman E, Soolingen DV, Warren RM. Use of light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum. Clinical Infectious Diseases. 2008 Jul 15;47(2):203-
  10. World Health Organization. Fluorescent light-emitting diode (LED) microscopy for diagnosis of tuberculosis: policy statement. Geneva: World Health Organization; 2011.
  11. Lawn SD, Nicol MP. Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol 2011;6(9):1067-82.
  12. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and Policy update: pg 10-3
  13. Carriquiry G, Otero L, Gonza´lez-Lagos E et al. A Diagnostic Accuracy Study of XpertHMTB/RIF in HIV-Positive Patients with high Clinical Suspicion of Pulmonary Tuberculosis in Lima, Peru. PLoS ONE 2012; 7 (9): e44626. doi:10.1371/journal.pone.0044626.
  14. S.Subbarao "Role and Efficiency Cbnaat in Diagnosis of Pulmonary Tuberculosis in Rntcp."IOSR Journal of Dental and Medical Sciences (IOSR-JDMS), vol. 17, no. 3, 2018, pp 51-55.
  15. Gupta PP, Mynalli AB, Yadav A. Diagnostic Role of Cartridge Based Nucleic Acid Amplification Test in Diagnosing Tuberculosis in Patients Co-infected with Human Immunodeficiency Virus. Journal of medical science and clinical 2017;5(5):21841-48.
  16. Giri PA, Deshpande JD, Phalke DB. Prevalence of pulmonary tuberculosis among HIV positive patients attending antiretroviral therapy clinic. North American journal of medical sciences. 2013 Jun;5(6):367.
  17. Patel AK, Thakrar SJ, Ghanchi FD. Clinical and laboratory profile of patients with TB/HIV coinfection: A case series of 50 patients. Lung India: official organ of Indian Chest Society. 2011 Apr;28(2):93.
  18. Kumar P, Sharma N, Sharma NC, Patnaik S. Clinical profile of tuberculosis in patients with HIV infection/AIDS. INDIAN JOURNAL OF CHEST DISEASES AND ALLIED SCIENCES. 2002 Jul;44(3):159-64.
  19. Affusim CC, Kesieme E, Abah VO. The pattern of presentation and prevalence of tuberculosis in HIV-seropositive patients seen at Benin City, Nigeria. ISRN Pulmonology. 2012 Mar 12;2012.

Corresponding Author

Dr Srujana Akella

Postgraduate, Department of Pulmonary Medicine, Andhra Medical College